shares elan biogen idec plunged monday firms suspended sales new multiple sclerosis tysabri patients death uselan biggest firm irish stock exchange expected receive boost new producton new york stock exchange shares irelandbased elan lost 70 us partner biogen idec shed 43 shares uk pharmaceutical firm phytopharm closed 1984 1515 pence london stock exchange monday said partner set pull deal experimental alzheimers disease treatmenttysabri approved use us last november widely tipped become worlds leading multiple sclerosis treatmentthe cases cited involved use tysabri avonex biogen idecs existing multiple sclerosis drugmost value company tysabri said ian hunter goodbody stockbrokers dublin
